Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06803498 · ClinicalTrials.gov registry record

Delivery Room Intervention and Evaluation Network

A clinical trial of Infant, Newborn and Resuscitation, sponsored by American Academy of Pediatrics.

Recruiting
Registry status
3,000,000
Enrollment target
1
Study location

NCT06803498: Recruiting study of Infant, Newborn and Resuscitation, sponsored by American Academy of Pediatrics.

NCT06803498 is a study of Infant, Newborn and Resuscitation that is actively recruiting participants, run by American Academy of Pediatrics. The registered enrollment target is 3,000,000 participants, above the 13,992-participant average among 14 other Infant, Newborn trials with a reported enrollment target (21341% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT06803498, a study of Infant, Newborn and Resuscitation, is actively recruiting participants, sponsored by American Academy of Pediatrics.

RECRUITING
Registry status
3,000,000 participants
Enrollment target
1
Study location

Study Summary

The American Academy of Pediatrics (AAP) convened the multi-center Delivery Room Intervention and Evaluation (DRIVE) Network to establish essential infrastructure to collect, coordinate, and analyze core demographic, resuscitative, and outcome data for an inclusive and diverse population of infants who receive delivery room resuscitation at participating centers. The DRIVE Network consists of delivery hospitals across the United States, covering a range of geographic, urban/rural, racial/ethnic diversity across the country. Together, DRIVE seeks to compare practice-level delivery system characteristics, identify best practices, evaluate outcomes from various interventions, and promote professional development through dissemination via the wide reach of the Neonatal Resuscitation Program.

Primary Outcome

The disposition of the patient after resuscitation including newborn nursery, neonatal ICU including a special care nursery or transitional nursery, palliative care, or transfer to other hospital

Conditions Studied

Infant, Newborn Resuscitation

Interventions

  • PROCEDURE Receipt of significant resuscitation intervention at birth

Study Locations (1)

Illinois

  • American Academy of Pediatrics - Itasca

Trial Details

FieldValue
Enrollment Target 3,000,000 participants
Start Date 2022-01-01
Est. Completion 2042-01-01
American Academy of Pediatrics

3 total trials

What NCT06803498 shows while recruiting

NCT06803498 is an observational study that tracks outcomes without assigning an intervention. Its 3,000,000 participants enrollment target places it among the larger protocols in the corpus, above the 13,992-participant average among 14 other Infant, Newborn trials with a reported enrollment target (21341% higher).

The record links to 2 conditions, with Infant, Newborn appearing as the primary indexed condition, and to 1 intervention - of which Receipt of significant resuscitation intervention at birth is the first listed.

NCT06803498 reports a single indexed study location in Illinois.

Frequently Asked Questions

What is clinical trial NCT06803498 about?

NCT06803498 is a clinical study titled "Delivery Room Intervention and Evaluation Network". The American Academy of Pediatrics (AAP) convened the multi-center Delivery Room Intervention and Evaluation (DRIVE) Network to establish essential infrastructure to collect, coordinate, and analyze core demographic, resuscitative, and outcome data for an inclusive and diverse population of infants ...

What is the current status of trial NCT06803498?

This trial is currently recruiting. The enrollment target is 3,000,000 participants. The study started on 2022-01-01. Estimated completion is 2042-01-01.

What conditions does trial NCT06803498 study?

This clinical trial studies the following conditions: Infant, Newborn, Resuscitation.

What interventions are being tested in trial NCT06803498?

The interventions under investigation include: Receipt of significant resuscitation intervention at birth (PROCEDURE).

Who is sponsoring clinical trial NCT06803498?

This trial is sponsored by American Academy of Pediatrics, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06803498 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Infant, Newborn

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06803498's enrollment target sits among peer trials

3,000,000 1st of 14 higher than 14 of 14 other Infant, Newborn trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Infant, Newborn trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02693223 · 3,892,063 participants

    Get With the Guidelines-Stroke Registry

  • NCT03813862 · 2,000,000 participants

    Observational Pharmaco-Epidemiology Research & Analysis

  • NCT06057181 · 2,000,000 participants

    Helix Research Network

  • NCT07022951 · 1,200,000 participants

    The Million Anesthesia Cases Study (MACS) - a Cohort Study of Preoperative Fasting and Perioperative Outcomes

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

More recruiting context for NCT06803498

Source: ClinicalTrials.gov NCT06803498, the US trial registry maintained by the National Library of Medicine. NCT06803498 (large enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.